Suresh V Kuchipudi

Aug 16, 2024 | post-gazette.com | Suresh V Kuchipudi

ACCOUNT SECTIONS OTHER CLASSIFIEDS CONTACT US / FAQ

Dec 10, 2023 | nature.com | Ching-Lin Hsieh |Andrew Horton |Xuping Xie |Hongjie Xia |Pei-Yong Shi |Andrew D Ellington | +7 more

AbstractThe ongoing evolution of SARS-CoV-2 into more easily transmissible and infectious variants has provided unprecedented insight into mutations enabling immune escape. Understanding how these mutations affect the dynamics of antibody-antigen interactions is crucial to the development of broadly protective antibodies and vaccines. Here we report the characterization of a potent neutralizing antibody (N3-1) identified from a COVID-19 patient during the first disease wave.

Sep 17, 2023 | inverse.com | Suresh V Kuchipudi

What is BA.2.86, and how is it related to earlier variants? BA.2.86, nicknamed Pirola, is a highly mutated new omicron sublineage of SARS-CoV-2 that was first detected in Denmark in July 2023. The World Health Organization announced that, as of Sept. 6, 2023, BA.2.86 has been detected in 11 countries. A variant is an alternate version of a virus — in this case, the SARS-CoV-2 virus that causes COVID-19 — that has some mutations or changes in its genetic code compared with the original.

Sep 12, 2023 | thederrick.com | Suresh V Kuchipudi

Sep 12, 2023 | caledonianrecord.com | Suresh V Kuchipudi

By Suresh V. Kuchipudi, Professor and Department Chair of Infectious Diseases and Microbiology, University of Pittsburgh The latest variant, or sublineage, of SARS-CoV-2 to emerge on the scene, BA.2.86, has public health experts on alert as COVID-19 hospitalizations begin to rise and the new variant makes its way across the globe.